Insider Transactions in Q1 2022 at Karuna Therapeutics, Inc. (KRTX)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2022
|
Stephen K. Brannan Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,728
-38.2%
|
$826,896
$107.38 P/Share
|
|
Mar 01
2022
|
Stephen K. Brannan Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,228
+22.16%
|
$71,596
$7.33 P/Share
|
|
Feb 15
2022
|
Laurie J Olson |
SELL
Open market or private sale
|
Direct |
1,000
-100.0%
|
$110,000
$110.0 P/Share
|
|
Feb 15
2022
|
Laurie J Olson |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+50.0%
|
$84,000
$84.86 P/Share
|
|
Feb 15
2022
|
Troy A. Ignelzi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,500
-5.67%
|
$166,500
$111.14 P/Share
|
|
Feb 15
2022
|
Troy A. Ignelzi Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+5.36%
|
$13,500
$9.2 P/Share
|
|
Feb 01
2022
|
Atul Pande |
SELL
Open market or private sale
|
Direct |
2,500
-100.0%
|
$275,000
$110.8 P/Share
|
|
Feb 01
2022
|
Atul Pande |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+50.0%
|
$40,000
$16.0 P/Share
|
|
Feb 01
2022
|
Stephen K. Brannan Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,728
-43.59%
|
$850,080
$110.05 P/Share
|
|
Feb 01
2022
|
Stephen K. Brannan Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,228
+25.18%
|
$61,368
$6.36 P/Share
|
|
Jan 03
2022
|
Atul Pande |
SELL
Open market or private sale
|
Direct |
2,500
-100.0%
|
$325,000
$130.44 P/Share
|
|
Jan 03
2022
|
Atul Pande |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+50.0%
|
$40,000
$16.0 P/Share
|
|
Jan 03
2022
|
Stephen K. Brannan Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,728
-25.57%
|
$1,004,640
$130.79 P/Share
|
|
Jan 03
2022
|
Stephen K. Brannan Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,228
+15.18%
|
$71,596
$7.33 P/Share
|